Table 4. Description of the cohort clinical pathological variables of the patients.
| Number (total number of patients: n=250) | % | |
|---|---|---|
| Age, years | ||
| < 49 | 139 | 55.6 |
| ≥49 | 111 | 44.4 |
| Tumor subtype | ||
| Squamous | 202 | 80.8 |
| Adenocarcinoma | 48 | 19.2 |
| Tumor size, pT | ||
| pT1 | 110 | 44.0 |
| pT2 | 128 | 51.2 |
| pT3/4 | 9 | 3.6 |
| NA | 3 | 1.2 |
| Tumor grade | ||
| I | 21 | 8.4 |
| II | 143 | 57.2 |
| III | 78 | 31.2 |
| NA | 8 | 3.2 |
| FIGO | ||
| I | 64 | 25.6 |
| II | 48 | 19.2 |
| III | 37 | 14.8 |
| IV | 7 | 2.8 |
| NA | 94 | 37.6 |
| Number of positive nodes | ||
| 0 | 151 | 60.4 |
| ≥ 1 | 97 | 38.8 |
| NA | 2 | 0.8 |
| Progression (over 235 months) | ||
| None | 210 | 84.0 |
| At least one | 21 | 11.6 |
| NA | 19 | 7.6 |
| Survival (over 235 months) | ||
| Censured | 190 | 76.0 |
| Dead | 49 | 19.6 |
| NA | 11 | 4.4 |